HC Wainwright Issues Positive Forecast for LYRA Earnings
Lyra Therapeutics, Inc. (NASDAQ:LYRA – Free Report) – Research analysts at HC Wainwright upped their Q2 2025 earnings estimates for shares of Lyra Therapeutics in a research report issued on Tuesday, June 10th. HC Wainwright analyst M. Caufield now anticipates that the company will post earnings of ($7.03) per share for the quarter, up from […]
